BusinessSun Pharma Plans ₹10,000 Crore Bond Sale to Refinance Organon Loan
Sun Pharma, India's largest drugmaker by market capitalization, plans to issue bonds worth ₹10,000 crore to refinance the loan taken for acquiring Organon. Earlier this year, Sun Pharma closed a syndication of an 18-month bridge loan of nearly $12 billion, which included the State Bank of India, the country's largest lender by assets.
Mint Companies·3h ago



